allodynia from glp 1 Can semaglutide (glucagon-like peptide-1 receptor agonist) lead to ? GLP-1 and its derived peptides

Copycat versions of Eli Lilly's diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week

Glucagon-like peptides (GLP-1 and GLP-2) are two proglucagon-derived intestinal hormones that mediate distinct physiological functions through two related receptors (GLP-1R and GLP-2R) which are important drug targets for metabolic disorders and Crohns disease, respectively

In fact, a recent KFF Health Tracking Poll found that approximately 1 in 8 U.S

These are signals, not definitive conclusionsbut they come directly from patients and may deserve further attention...

Meals and snacks with GLP-1 Friendly labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like Wegovy and Zepbound to lose weight.

From a pharma strategy perspective, this is a prudent and timely regulatory signal